
Sign up to save your podcasts
Or


Welcome back to Research Renaissance, presented by the Karen Toffler Charitable Trust. In this episode, host Deborah Westphal explores the cutting edge of rare disease research with special guests Andrew Rosen, CEO of the National Ataxia Foundation (NAF), and Dr. Lauren Moore, NAF’s Chief Scientific Officer.
Together, they unpack how the NAF has evolved from a small support-focused nonprofit into a strategic, science-driven organization that’s advancing treatments and reshaping what’s possible for people living with ataxia—a rare, progressive neurological condition affecting movement and coordination.
🔍 In this episode, we explore:
🧠 Key Takeaway:
Treatments are on the horizon—but getting there takes relentless advocacy, strategic funding, and courageous participation from patients and families. As Andrew puts it: “We’d love to put ourselves out of business someday. Until then, we’re here to build the infrastructure that gets us there.”
🌐 Resources & Links:
🎧 Subscribe to Research Renaissance
Available on Apple Podcasts, Spotify, and all major platforms. For more conversations at the intersection of neuroscience, technology, and purpose-driven science, follow us at tofflertrust.org or get in touch.
To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org.
Technical Podcast Support by Jon Keur at Wayfare Recording Co.
By Karen Toffler Charitable TrustWelcome back to Research Renaissance, presented by the Karen Toffler Charitable Trust. In this episode, host Deborah Westphal explores the cutting edge of rare disease research with special guests Andrew Rosen, CEO of the National Ataxia Foundation (NAF), and Dr. Lauren Moore, NAF’s Chief Scientific Officer.
Together, they unpack how the NAF has evolved from a small support-focused nonprofit into a strategic, science-driven organization that’s advancing treatments and reshaping what’s possible for people living with ataxia—a rare, progressive neurological condition affecting movement and coordination.
🔍 In this episode, we explore:
🧠 Key Takeaway:
Treatments are on the horizon—but getting there takes relentless advocacy, strategic funding, and courageous participation from patients and families. As Andrew puts it: “We’d love to put ourselves out of business someday. Until then, we’re here to build the infrastructure that gets us there.”
🌐 Resources & Links:
🎧 Subscribe to Research Renaissance
Available on Apple Podcasts, Spotify, and all major platforms. For more conversations at the intersection of neuroscience, technology, and purpose-driven science, follow us at tofflertrust.org or get in touch.
To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org.
Technical Podcast Support by Jon Keur at Wayfare Recording Co.